REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 184 filers reported holding REGENXBIO INC in Q4 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $261,000 | -97.7% | 9,488 | -97.0% | 0.00% | -100.0% |
| Q2 2020 | $11,484,000 | -14.4% | 311,806 | -24.7% | 0.00% | -25.0% |
| Q1 2020 | $13,414,000 | -25.2% | 414,279 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $17,935,000 | -4.1% | 437,767 | -16.7% | 0.00% | 0.0% |
| Q3 2019 | $18,700,000 | -31.6% | 525,255 | -1.3% | 0.00% | -33.3% |
| Q2 2019 | $27,325,000 | -6.4% | 531,930 | +4.5% | 0.01% | -14.3% |
| Q1 2019 | $29,178,000 | +5.2% | 509,129 | -23.0% | 0.01% | 0.0% |
| Q4 2018 | $27,740,000 | -41.7% | 661,278 | +5.0% | 0.01% | -30.0% |
| Q3 2018 | $47,569,000 | +49.6% | 630,064 | +42.2% | 0.01% | +42.9% |
| Q2 2018 | $31,802,000 | +12420.5% | 443,224 | +5118.1% | 0.01% | – |
| Q1 2018 | $254,000 | – | 8,494 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 839,139 | $35,177,000 | 6.39% |
| Sonic Fund II, L.P. | 188,786 | $7,914,000 | 4.47% |
| ArchPoint Investors | 297,355 | $12,465,000 | 3.73% |
| Redmile Group, LLC | 2,008,001 | $84,175,000 | 1.47% |
| RTW INVESTMENTS, LP | 1,845,366 | $77,358,000 | 1.17% |
| WS MANAGEMENT LLLP | 210,729 | $8,834,000 | 0.94% |
| FRAZIER MANAGEMENT LLC | 235,809 | $9,885,000 | 0.79% |
| Integral Health Asset Management, LLC | 55,000 | $2,306,000 | 0.66% |
| Sofinnova Investments, Inc. | 127,593 | $5,349,000 | 0.32% |
| HHLR ADVISORS, LTD. | 456,000 | $19,116,000 | 0.25% |